Q4 2019 Holdings
Filed 2020-02-14 | 57 holdings | $133.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $76.5M | 7,206,458 | 57.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $36.1M | 3,579,023 | 27.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $8.9M | 1,627,568 | 6.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $6.4M | 766,148 | 4.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.0M | 25,000 | 3.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $131.7K | 2,179,735 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $118.5K | 3,079,155 | 0.1% |
| AC Immune SA(ACIU) | SHS | H00263105 | $96.6K | 11,342,505 | 0.1% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $94.0K | 1,716,734 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $72.1K | 2,642,405 | 0.1% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $59.5K | 2,978,683 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $54.6K | 9,559,642 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $47.0K | 3,358,332 | 0.0% |
| Merus N V | COM | N5749R100 | $44.6K | 3,169,654 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $38.9K | 7,361,801 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $35.7K | 7,783,001 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $33.1K | 2,309,109 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $27.5K | 1,998,276 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $25.6K | 1,949,075 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $24.5K | 785,851 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $19.4K | 5,349,905 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $16.7K | 17,426,968 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $15.9K | 999,996 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $15.5K | 1,764,784 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $15.3K | 939,565 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $14.7K | 183,834 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM | 29668H708 | $14.5K | 2,640,565 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $13.3K | 5,346,272 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $12.2K | 1,141,974 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $10.9K | 6,929,690 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $10.8K | 1,436,429 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $10.6K | 1,832,484 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $10.4K | 656,483 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $10.3K | 2,687,738 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.0K | 451,009 | 0.0% |
| Verastem Inc | COM | 92337C104 | $8.5K | 6,328,994 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $8.1K | 845,405 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $7.8K | 3,284,072 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.8K | 1,180,553 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $6.0K | 925,724 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.8K | 682,630 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $4.6K | 625,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.4K | 1,137,764 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $4.3K | 2,100,305 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $4.3K | 1,000,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M205 | $3.9K | 1,733,036 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.8K | 345,196 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $3.0K | 734,301 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $2.1K | 143,567 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | $2.1K | 6,194,925 | 0.0% |